Resmed (RMD) net income: $1.5B
Resmed reported a net income of $1.5B for the year ended Jun 30, 2026, up 8.7% from $1.4B a year earlier.
From Resmed's filings with the SEC · Read the filing · RMD stock page
Resmed net income by year
#270 of 3,748 US companies by net income · See the full ranking
| Year ended | Net income | Change |
|---|---|---|
| Jun 30, 2026 | $1.5B | +9% |
| Jun 30, 2025 | $1.4B | +37% |
| Jun 30, 2024 | $1B | +14% |
| Jun 30, 2023 | $898M | +15% |
| Jun 30, 2022 | $779M | +64% |
| Jun 30, 2021 | $475M | – |
Net income of similar companies
Companies in the same industry as Resmed, by SEC industry code, with the closest net income. Each name opens the same page for that company.
| Company | Net income, latest year | Year ended |
|---|---|---|
| 3M | $3.2B | Dec 31, 2025 |
| Stryker | $3.2B | Dec 31, 2025 |
| Becton Dickinson | $1.7B | Sep 30, 2025 |
| Solventum | $1.6B | Dec 31, 2025 |
| Resmed | $1.5B | Jun 30, 2026 |
| Dexcom | $836M | Dec 31, 2025 |
| Globus Medical | $538M | Dec 31, 2025 |
Questions and answers
What is Resmed's net income?
Resmed reported a net income of $1.5B for the year ended Jun 30, 2026, up 8.7% from $1.4B a year earlier.
Numbers as reported in Resmed's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology